We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NEW MEDICARE REIMBURSEMENT SYSTEM POSES COMPLIANCE RISK
NEW MEDICARE REIMBURSEMENT SYSTEM POSES COMPLIANCE RISK
January 21, 2004
As HHS implements the new Medicare reimbursement system for many physician-administered outpatient drugs, pharma firms are likely to find themselves confronted by many of the same fraud and abuse issues they have had to deal with under the much-criticized average wholesale price (AWP) system — as well as some new issues — according to a healthcare legal expert.